Oxygen-Regulated Expression of the RNA-Binding Proteins RBM3 and CIRP by a HIF-1-Independent Mechanism
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Anti-RBM3 Antibody [HB9] (ARG23691)
Product datasheet [email protected] ARG23691 Package: 50 μg anti-RBM3 antibody [HB9] Store at: -20°C Summary Product Description Mouse Monoclonal antibody [HB9] recognizes RBM3 Tested Reactivity Hu Tested Application ICC/IF Specificity The antibody reacts against the recombinant human RBM3 full length under oxidative conditions without DTT or under reducing conditions with DTT. Cross reactivity of the antibody with the recombinant human Cold inducible Binding protein (CIRBP, full length 20.5 kDa) could not be detected. The apparent MW of hRBM3 in SDS-PAGE is ~17 kDa. Host Mouse Clonality Monoclonal Clone HB9 Isotype IgG1 Target Name RBM3 Antigen Species Human Immunogen Human RNA-binding protein 3. Conjugation Un-conjugated Alternate Names RNPL; IS1-RNPL; RNA-binding motif protein 3; RNA-binding protein 3 Application Instructions Application table Application Dilution ICC/IF 1:50 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 17 kDa Properties Form Liquid Purification Purification with Protein G. The IgG1 fraction was purified by affinity chromatography. Buffer PBS (pH 7.4) and 0.01% Sodium azide. Preservative 0.01% Sodium azide Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use. -
Identification of the Rna Binding Protein Rbm3 As a Novel Effector of Β-Catenin Signaling and Colon Cancer Stem Cells
IDENTIFICATION OF THE RNA BINDING PROTEIN RBM3 AS A NOVEL EFFECTOR OF β-CATENIN SIGNALING AND COLON CANCER STEM CELLS By Anand Venugopal Submitted to the graduate degree program in Molecular and Integrative Physiology and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________ Chairperson Shrikant Anant, Ph.D. ________________________________ Roy Jensen, M.D. ________________________________ Andrew Godwin, Ph.D. ________________________________ Danny Welch, Ph.D. ________________________________ John Wood, Ph.D. Date Defended: ________________________________March 14, 2014 The Dissertation Committee for Anand Venugopal certifies that this is the approved version of the following dissertation: IDENTIFICATION OF THE RNA BINDING PROTEIN RBM3 AS A NOVEL EFFECTOR OF β-CATENIN SIGNALING AND COLON CANCER STEM CELLS ________________________________ Chairperson Shrikant Anant, Ph.D. Date approved: ________________________________March 14, 2014 ii Abstract The intestinal epithelium is one of the fastest renewing tissues within the adult. This renewal is primarily driven by the intestinal epithelial stem cell compartment and homeostasis of this compartment needs to be strictly maintained. Loss of regulation can lead to hyperplasia and subsequent malignant transformation. Moreover, cancers are also thought to contain a stem cell population which maintains long term tumor viability and recurrence following therapy. Therefore, a thorough understanding of the molecular machinery that governs stem cell homeostasis can further our understanding of colon cancer initiation and progression. The RNA binding protein RBM3 is upregulated in many solid tumors including colon, prostate and breast. It also serves as a proto-oncogene inducing the malignant transformation of normal cells when overexpressed. To further characterize the mechanism, we overexpressed RBM3 in DLD-1 and HCT 116 colon cancer cell lines. -
1 Supporting Information for a Microrna Network Regulates
Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia. -
Human RBM3 ELISA Kit (ARG81349)
Product datasheet [email protected] ARG81349 Package: 96 wells Human RBM3 ELISA Kit Store at: 4°C Summary Product Description ARG81349 Human RBM3 ELISA Kit is an Enzyme Immunoassay kit for the quantification of Human RBM3 in serum and plasma. Tested Reactivity Hu Tested Application ELISA Specificity No significant cross reactivity to Cold inducible Binding protein (CIRBP), human. Target Name RBM3 Conjugation HRP Conjugation Note Substrate: TMB and read at 450 nm. Sensitivity 10 pg/ml Sample Type Serum and plasma. Standard Range 31.25 - 2000 pg/ml Sample Volume 50 µl Alternate Names RNPL; IS1-RNPL; RNA-binding motif protein 3; RNA-binding protein 3 Application Instructions Assay Time ~ 2.5 hours Properties Form 96 well Storage instruction Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol RBM3 Gene Full Name RNA binding motif (RNP1, RRM) protein 3 Background This gene is a member of the glycine-rich RNA-binding protein family and encodes a protein with one RNA recognition motif (RRM) domain. Expression of this gene is induced by cold shock and low oxygen tension. A pseudogene exists on chromosome 1. Multiple alternatively spliced transcript variants that are predicted to encode different isoforms have been characterized although some of these variants fit nonsense-mediated decay (NMD) criteria. -
Human RBM3 ELISA Assay Kit
Human RBM3 ELISA Assay Kit BTRBM-001 For quantitative determination of human RNA-binding protein 3 96 Determinations 2°C – 8 °C For research use only Not for diagnostic use RBM3 ELISA Assay Kit 1 of 14 Catalog Number: BTRBM001 www.EagleBio.com Contents Short Review 3 Intended Use 4 Test principle 5 Safety warning and precautions 5 Storage 6 Components of the assay system 6 Sample preparation and storage 7 Critical parameters 7 Preparation of reagents 8 Assay protocol 8 Protocol summary 9 Scheme of the plate 10 Data processing 10 Additional information 11 Specificity 11 Sensitivity 11 Linearity 11 Recovery 11 Reproducibility 12 Troubleshooting 13 Related Products 14 BioTeZ Berlin-Buch GmbH Robert-Rössle-Str. 10, Haus 72 13125 Berlin Tel.: ++49 (0)30-9489 3322 Fax: ++49 (0)30-949 2008 e-mail: [email protected] http://www.biotez.de This manual is valid from May, 2016 RBM3 ELISA Assay Kit 2 of 14 Catalog Number: BTRBM001 www.EagleBio.com Short Review The RNA-binding protein 3 (RBM3) is a member of the glycine-rich RNA-binding protein family. The exact role of the cold shock protein RBM3 is not yet clear [2, 6]. The role of mRNA-binding proteins can be attributed to a regulation of mRNA splicing, stability, transport and ultimately the translation of mRNA into proteins. RBM3 consists of 157 amino acids with a predicted mass of 17 kD (1, 2) and is one of the few proteins that are upregulated at low temperature [3-5]. It is known that RBM3 acts especially in cellular stress (eg. -
Molecular Interactions Underpinning the Phenotype of Hibernation in Mammals Matthew T
© 2019. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2019) 222, jeb160606. doi:10.1242/jeb.160606 REVIEW Molecular interactions underpinning the phenotype of hibernation in mammals Matthew T. Andrews* ABSTRACT most mammals. This Review covers recent advances in the Mammals maintain a constant warm body temperature, facilitating a molecular biology of hibernation, with a focus on molecular wide variety of metabolic reactions. Mammals that hibernate have the interactions underpinning the hibernation phenotype. Specific – ability to slow their metabolism, which in turn reduces their body topics include the torpor arousal cycle, the role of small temperature and leads to a state of hypothermic torpor. For this molecules, changes in gene expression, cold-inducible RNA- metabolic rate reduction to occur on a whole-body scale, molecular binding proteins, the somatosensory system and emerging interactions that change the physiology of cells, tissues and organs information on hibernating primates. This new information not are required, resulting in a major departure from normal mammalian only is beginning to explain how natural hibernators survive homeostasis. The aim of this Review is to cover recent advances in the physiological extremes that would be lethal to most mammals, but molecular biology of mammalian hibernation, including the role of also identifies molecular mechanisms that may prove useful to small molecules, seasonal changes in gene expression, cold- human medicine. inducible RNA-binding proteins, -
Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing -
RBM3: a Prognostic and Treatment Predictive Biomarker
RBM3: A Prognostic and Treatment Predictive Biomarker Introduction it has also been shown that RBM3 attenu- Cancer is continuously a major health ates stem cell-like properties in prostate problem throughout the world. In 2008, cancer cells6. there were an estimated 12.7 million new cancer cases world-wide, and 7.6 RBM3 monoclonal antibody million deaths that could be attributed to The monoclonal Anti-RBM3 antibody cancer1. Due to a world population with AMAb90655, used in all cases presented an increased life-expectancy, there is no here (available for purchase from Atlas reason to expect a decline in cancer inci- Antibodies, Stockholm, Sweden, atlasan- dence in the near future2. tibodies.com), has shown excellent spe- cificity in Western Blot analysis of human Cancer, though often denoted as a sin- cell lines, and is routinely used for stain- gular disease, is truly a multitude of dis- ing of formalin fixed paraffin embedded eases. This understanding has evolved tissue in IHC. A representative image of over the years, and though common immunohistochemical staining using the knowledge today, many patients are still RBM3 monoclonal antibody AMAb90655 not receiving optimal treatment for their can be seen in Figure 1. disease. For cancer patients to receive a more individualized treatment, there is RBM3 as a prognostic biomarker still a need for new and better ways to After identification of RBM3 as a poten- stratify patients. The classical, pathol- tial prognostic biomarker, RBM3 protein ogy based, prognostic factors such as expression has been analyzed using stage and grade of the tumor are insuf- AMAb90655 in many different patient co- ficient for a correct estimation of patient horts from various forms of cancer. -
The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights Into Cell Differentiation and Function
International Journal of Molecular Sciences Article The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function Yashwanth Subbannayya 1 , Markus Haug 1, Sneha M. Pinto 1, Varshasnata Mohanty 2, Hany Zakaria Meås 1, Trude Helen Flo 1, T.S. Keshava Prasad 2 and Richard K. Kandasamy 1,* 1 Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491 Trondheim, Norway; [email protected] (Y.S.); [email protected] (M.H.); [email protected] (S.M.P.); [email protected] (H.Z.M.); trude.fl[email protected] (T.H.F.) 2 Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore 575018, India; [email protected] (V.M.); [email protected] (T.S.K.P.) * Correspondence: [email protected] Abstract: CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. The activation and functional status of CD4+ T cells is important for adequate responses to pathogen infections but has also been associated with auto-immune disorders and survival in several cancers. In the current study, we carried out a label-free high-resolution FTMS-based proteomic profiling of resting and T cell receptor-activated (72 h) primary human CD4+ T cells from peripheral blood of healthy donors as well as SUP-T1 cells. We identified 5237 proteins, of which significant alterations in the levels of 1119 proteins were observed between resting and activated CD4+ T cells. -
Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture
RESEARCH ARTICLE Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture Andrea Bedoya-López1, Karel Estrada2, Alejandro Sanchez-Flores2, Octavio T. Ramírez3, Claudia Altamirano4, Lorenzo Segovia5, Juan Miranda-Ríos1, Mauricio A. Trujillo-Roldán1, Norma A. Valdez-Cruz1* 1 Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México, 2 Unidad Universitaria de Apoyo Bioinformático, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mor. México, 3 Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mor. México, 4 Escuela de Ingeniería Bioquímica, Pontificia OPEN ACCESS Universidad Católica de Valparaíso, Valparaíso, Chile, 5 Departamento de Ingeniería Celular y Biocatálisis. Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mor. México Citation: Bedoya-López A, Estrada K, Sanchez- Flores A, Ramírez OT, Altamirano C, Segovia L, et al. * [email protected] (2016) Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture. PLoS Abstract ONE 11(3): e0151529. doi:10.1371/journal. pone.0151529 Recombinant proteins are widely used as biopharmaceuticals, but their production by mam- Editor: Jonathan -
Downloaded from Ftp://Ftp.Uniprot.Org/ on July 3, 2019) Using Maxquant (V1.6.10.43) Search Algorithm
bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function Yashwanth Subbannayya1, Markus Haug1, Sneha M. Pinto1, Varshasnata Mohanty2, Hany Zakaria Meås1, Trude Helen Flo1, T.S. Keshava Prasad2 and Richard K. Kandasamy1,* 1Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, N-7491 Trondheim, Norway 2Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore, India *Correspondence to: Professor Richard Kumaran Kandasamy Norwegian University of Science and Technology (NTNU) Centre of Molecular Inflammation Research (CEMIR) PO Box 8905 MTFS Trondheim 7491 Norway E-mail: [email protected] (Kandasamy R K) Tel.: +47-7282-4511 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Abstract CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. -
Impact of RNA‑Binding Motif 3 Expression on the Whole Transcriptome of Prostate Cancer Cells: an RNA Sequencing Study
ONCOLOGY REPORTS 40: 2307-2315, 2018 Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study QINGZHUO DONG1, CHENGCHENG LV1, GEJUN ZHANG1,2, ZI YU1,2, CHUIZE KONG2, CHENG FU1 and YU ZENG1 1Department of Urology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042; 2Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China Received March 3, 2018; Accepted July 25, 2018 DOI: 10.3892/or.2018.6618 Abstract. RNA-binding motif 3 (RBM3) is a cold-shock Introduction protein that has been previously shown to attenuate cancer stem cell-like features in prostate cancer (PCa) cells. However, There were 4,292,000 new cases of cancer and 2,814,000 cases the mechanism underlying RBM3 regulation in PCa cells is of cancer-associated mortality reported in 2015 in China (1). largely unknown. The present study investigated the impact Among all types of cancer, prostate cancer (PCa) was diag- of RBM3 expression on the whole transcriptome of PCa nosed in ~603,000 men, and over 26,000 men succumbed to cells using high-throughput RNA sequencing (RNA-seq). this disease (1). Although the incidence and mortality rates of Differentially expressed genes (DEGs) that were identified PCa remain lower in China than in Western countries, they through RNA-seq were applied to Gene Ontology (GO), are increasing rapidly. Thus, PCa has become one of the major pathway analysis, pathway-action networks and protein-protein healthy issues for men in China.